Royal Bank of Canada
PPH icon

Royal Bank of Canada’s VanEck Pharmaceutical ETF PPH Stock Holding History

Royal Bank of Canada’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.5M Buy
361,001
+322,878
+847% +$34.4M 0.01% 1063
2025
Q4 		$3.93M Sell
38,123
-26,466
-41% -$2.57M ﹤0.01% 2615
2025
Q3 		$5.84M Buy
64,589
+29,426
+84% +$2.58M ﹤0.01% 2555
2025
Q2 		$3.09M Sell
35,163
-32,433
-48% -$2.81M ﹤0.01% 2961
2025
Q1 		$6.16M Buy
67,596
+23,491
+53% +$2.12M ﹤0.01% 2110
2024
Q4 		$3.81M Buy
44,105
+1,032
+2% +$93.3K ﹤0.01% 2529
2024
Q3 		$4.09M Buy
43,073
+13,222
+44% +$1.26M ﹤0.01% 2441
2024
Q2 		$2.73M Buy
29,851
+5,750
+24% +$513K ﹤0.01% 2666
2024
Q1 		$2.19M Sell
24,101
-3,135
-12% -$274K ﹤0.01% 2847
2023
Q4 		$2.21M Buy
27,236
+4,095
+18% +$321K ﹤0.01% 2987
2023
Q3 		$1.85M Sell
23,141
-31,128
-57% -$2.51M ﹤0.01% 2911
2023
Q2 		$4.28M Buy
54,269
+6,027
+12% +$472K ﹤0.01% 2209
2023
Q1 		$3.75M Buy
48,242
+3,920
+9% +$302K ﹤0.01% 2307
2022
Q4 		$3.44M Sell
44,322
-12,061
-21% -$890K ﹤0.01% 2430
2022
Q3 		$3.79M Sell
56,383
-3,351
-6% -$247K ﹤0.01% 2303
2022
Q2 		$4.59M Buy
59,734
+26,114
+78% +$2.04M ﹤0.01% 2172
2022
Q1 		$2.68M Buy
33,620
+4,333
+15% +$332K ﹤0.01% 2786
2021
Q4 		$2.25M Buy
29,287
+14,236
+95% +$1.06M ﹤0.01% 3049
2021
Q3 		$1.1M Buy
15,051
+800
+6% +$59.7K ﹤0.01% 3589
2021
Q2 		$1.04M Sell
14,251
-51,755
-78% -$3.69M ﹤0.01% 3604
2021
Q1 		$4.55M Buy
66,006
+41,441
+169% +$2.85M ﹤0.01% 2311
2020
Q4 		$1.63M Sell
24,565
-9,557
-28% -$612K ﹤0.01% 3098
2020
Q3 		$2.12M Sell
34,122
-22,108
-39% -$1.4M ﹤0.01% 2645
2020
Q2 		$3.5M Buy
56,230
+37,430
+199% +$2.26M ﹤0.01% 2195
2020
Q1 		$1.02M Sell
18,800
-5,338
-22% -$329K ﹤0.01% 3019
2019
Q4 		$1.55M Buy
24,138
+11,110
+85% +$669K ﹤0.01% 3099
2019
Q3 		$742K Sell
13,028
-39,101
-75% -$2.24M ﹤0.01% 3569
2019
Q2 		$3.06M Buy
52,129
+27,907
+115% +$1.62M ﹤0.01% 2435
2019
Q1 		$1.47M Buy
24,222
+6,342
+35% +$375K ﹤0.01% 2910
2018
Q4 		$978K Buy
17,880
+7,897
+79% +$478K ﹤0.01% 3177
2018
Q3 		$642K Buy
9,983
+75
+0.8% +$4.67K ﹤0.01% 3717
2018
Q2 		$585K Sell
9,908
-2,300
-19% -$133K ﹤0.01% 3674
2018
Q1 		$694K Buy
12,208
+920
+8% +$55K ﹤0.01% 3453
2017
Q4 		$670K Sell
11,288
-1,925
-15% -$110K ﹤0.01% 3567
2017
Q3 		$764K Buy
13,213
+2,203
+20% +$125K ﹤0.01% 3457
2017
Q2 		$651K Buy
11,010
+792
+8% +$44.8K ﹤0.01% 3457
2017
Q1 		$564K Sell
10,218
-17,680
-63% -$959K ﹤0.01% 3546
2016
Q4 		$1.47M Buy
27,898
+15,943
+133% +$852K ﹤0.01% 2827
2016
Q3 		$687K Sell
11,955
-1,707
-12% -$102K ﹤0.01% 3450
2016
Q2 		$800K Sell
13,662
-2,525
-16% -$147K ﹤0.01% 3292
2016
Q1 		$931K Sell
16,187
-6,267
-28% -$371K ﹤0.01% 3124
2015
Q4 		$1.47M Buy
22,454
+8,323
+59% +$537K ﹤0.01% 2791
2015
Q3 		$890K Buy
14,131
+665
+5% +$46.7K ﹤0.01% 2970
2015
Q2 		$952K Sell
13,466
-118
-0.9% -$8.5K ﹤0.01% 2960
2015
Q1 		$954K Sell
13,584
-2,724
-17% -$185K ﹤0.01% 2922
2014
Q4 		$1.05M Sell
16,308
-826
-5% -$52.6K ﹤0.01% 2876
2014
Q3 		$1.09M Sell
17,134
-6,805
-28% -$421K ﹤0.01% 2778
2014
Q2 		$1.49M Buy
23,939
+11,915
+99% +$708K ﹤0.01% 2512
2014
Q1 		$701K Buy
12,024
+4,149
+53% +$235K ﹤0.01% 3075
2013
Q4 		$418K Sell
7,875
-3,307
-30% -$167K ﹤0.01% 3561
2013
Q3 		$535K Buy
11,182
+275
+3% +$13K ﹤0.01% 3329
2013
Q2 		$495K Buy
+10,907
New +$504K ﹤0.01% 3170

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Royal Bank of Canada's PPH Position: Q1 2026 in Review

Royal Bank of Canada increased its VanEck Pharmaceutical ETF (PPH) stake by 847% in Q1 2026, buying an estimated $34.4M and bringing the position to 361,001 shares worth $37.5M. The position accounts for 0.01% of the portfolio, ranked #1063.

Royal Bank of Canada first reported a position in PPH in Q2 2013 and has held it in 52 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Royal Bank of Canada held 361,001 shares of VanEck Pharmaceutical ETF worth $37.5M as of Q1 2026.
  • Royal Bank of Canada bought 322,878 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $34.4M.
  • VanEck Pharmaceutical ETF made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1063 holding.
  • Royal Bank of Canada first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 52 quarters since.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.